# DESCRIPTION

## BACKGROUND OF THE INVENTION

- motivate oral vaccines

## BRIEF SUMMARY OF THE INVENTION

- introduce immunogenic compositions
- describe delivery to ileum
- specify immunogenic biological agent
- detail expression vector
- describe adjuvant
- specify delivery agent
- describe enteric coating
- outline immunogenic composition forms
- summarize method of delivery

## DETAILED DESCRIPTION OF THE INVENTION

- introduce immunogenic biological agents and their delivery to the ileum for therapeutic response

### I. Definitions

- define immunogenic
- define biological agent
- define immunogenic biological agent
- define antigen
- define immunogenically effective dose
- define humoral immune responses
- define cell mediated immune responses
- define ileum
- define enteric coating
- define disintegrate
- define chimeric or recombinant
- define expression vector
- define promoter
- define operably linked
- define heterologous
- define nucleic acid
- define therapeutic dose
- define antibody
- define T cells
- define adaptive immune response
- define antigen presenting cells
- define adjuvant

### II. Immunogenic Biological Agents

- define immunogenic biological agents
- describe polypeptide examples
- describe carbohydrate examples
- describe lipid examples
- describe polynucleotide examples
- explain expression of target immunogen
- introduce expression vectors
- describe virally-derived vectors
- describe transcriptional and translational control sequences
- introduce immunogens
- describe viral antigens
- describe bacterial, fungal, and parasite antigens
- introduce adjuvants

### III. Targeted Delivery Systems

- introduce enteric coatings
- describe pH-sensitive polymers
- discuss biodegradable polymers
- explain osmotic-controlled release oral delivery systems
- describe combination polymers for delivery to the ileum
- introduce frequency or radio-controlled capsules
- describe formulations for prophylactic and therapeutic purposes
- discuss pharmaceutical compositions for oral delivery
- summarize additional pharmaceutical ingredients

### IV. Immune Responses and Vaccines

- introduce immune responses to pharmaceutical compositions
- describe prophylactic and therapeutic uses of pharmaceutical compositions
- discuss administration and dosage of pharmaceutical compositions
- explain monitoring of immune responses
- summarize evaluation of immune responses

### V. Examples

- motivate vaccine delivery to intestine
- describe limitations of current methods
- introduce Example 1: human study of vaccine delivery
- describe vaccine composition and administration
- present results of Example 1: ASC and IFN-Î³ responses
- present results of Example 1: MN antibody titers
- introduce Example 2: tablet formulation and testing
- describe tablet composition and manufacturing
- present results of Example 2: tablet performance in monkeys
- introduce Example 3: phase 1 clinical study
- describe study design and vaccine preparation
- present results of Example 3: ASC and MN responses
- introduce Example 4: in vitro testing of enteric coatings
- present results of Example 4: dissolution times and pH effects
- present example
- measure antibody responses
- discuss results
- describe materials and methods
- outline clinical protocol and enrollment
- detail randomization and masking
- describe vaccine composition
- outline endpoints and statistical analysis
- provide disclaimer and incorporate references

